nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—NQO2—Parkinson's disease	0.444	0.569	CbGaD
Imatinib—ABL1—Parkinson's disease	0.233	0.299	CbGaD
Imatinib—CYP2D6—Parkinson's disease	0.0604	0.0774	CbGaD
Imatinib—ABCB1—Parkinson's disease	0.0431	0.0552	CbGaD
Imatinib—KIT—myenteric nerve plexus—Parkinson's disease	0.00509	0.0637	CbGeAlD
Imatinib—Nilotinib—MAPK8—Parkinson's disease	0.00221	0.367	CrCbGaD
Imatinib—Ponatinib—ABL1—Parkinson's disease	0.00152	0.252	CrCbGaD
Imatinib—NTRK1—midbrain—Parkinson's disease	0.00137	0.0172	CbGeAlD
Imatinib—NQO2—hindbrain—Parkinson's disease	0.00124	0.0156	CbGeAlD
Imatinib—CA1—nerve—Parkinson's disease	0.00121	0.0152	CbGeAlD
Imatinib—ABCA3—medulla oblongata—Parkinson's disease	0.00119	0.0149	CbGeAlD
Imatinib—Nilotinib—ABL1—Parkinson's disease	0.00112	0.186	CrCbGaD
Imatinib—DDR1—medulla oblongata—Parkinson's disease	0.0011	0.0137	CbGeAlD
Imatinib—ABCA3—midbrain—Parkinson's disease	0.00109	0.0136	CbGeAlD
Imatinib—ABCA3—spinal cord—Parkinson's disease	0.00106	0.0133	CbGeAlD
Imatinib—DDR1—midbrain—Parkinson's disease	0.001	0.0126	CbGeAlD
Imatinib—SLC47A1—hindbrain—Parkinson's disease	0.000998	0.0125	CbGeAlD
Imatinib—KIT—hindbrain—Parkinson's disease	0.000992	0.0124	CbGeAlD
Imatinib—DDR1—spinal cord—Parkinson's disease	0.000978	0.0122	CbGeAlD
Imatinib—ABCA3—head—Parkinson's disease	0.000942	0.0118	CbGeAlD
Imatinib—CA3—forebrain—Parkinson's disease	0.000895	0.0112	CbGeAlD
Imatinib—ABCA3—nervous system—Parkinson's disease	0.000893	0.0112	CbGeAlD
Imatinib—ABL1—hindbrain—Parkinson's disease	0.000864	0.0108	CbGeAlD
Imatinib—ABCA3—central nervous system—Parkinson's disease	0.00086	0.0108	CbGeAlD
Imatinib—ABCA3—cerebellum—Parkinson's disease	0.00084	0.0105	CbGeAlD
Imatinib—PDGFRA—embryo—Parkinson's disease	0.000776	0.00972	CbGeAlD
Imatinib—DDR1—cerebellum—Parkinson's disease	0.000775	0.00971	CbGeAlD
Imatinib—CA3—cardiovascular system—Parkinson's disease	0.000756	0.00947	CbGeAlD
Imatinib—NQO2—brainstem—Parkinson's disease	0.000713	0.00893	CbGeAlD
Imatinib—HIPK4—brain—Parkinson's disease	0.00069	0.00864	CbGeAlD
Imatinib—PDGFRA—forebrain—Parkinson's disease	0.000686	0.00859	CbGeAlD
Imatinib—CSF1R—embryo—Parkinson's disease	0.000683	0.00856	CbGeAlD
Imatinib—ABCA3—brain—Parkinson's disease	0.000682	0.00855	CbGeAlD
Imatinib—PIP4K2C—medulla oblongata—Parkinson's disease	0.000677	0.00848	CbGeAlD
Imatinib—CA7—midbrain—Parkinson's disease	0.000644	0.00806	CbGeAlD
Imatinib—CA12—forebrain—Parkinson's disease	0.000633	0.00793	CbGeAlD
Imatinib—DDR1—brain—Parkinson's disease	0.00063	0.00789	CbGeAlD
Imatinib—KIT—embryo—Parkinson's disease	0.00062	0.00777	CbGeAlD
Imatinib—PIP4K2C—midbrain—Parkinson's disease	0.000619	0.00775	CbGeAlD
Imatinib—PDGFRB—embryo—Parkinson's disease	0.000606	0.00759	CbGeAlD
Imatinib—CSF1R—forebrain—Parkinson's disease	0.000604	0.00757	CbGeAlD
Imatinib—PIP4K2C—spinal cord—Parkinson's disease	0.000604	0.00756	CbGeAlD
Imatinib—CA2—hindbrain—Parkinson's disease	0.000588	0.00736	CbGeAlD
Imatinib—CA14—medulla oblongata—Parkinson's disease	0.000587	0.00735	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—Parkinson's disease	0.00058	0.00727	CbGeAlD
Imatinib—SLC47A1—brainstem—Parkinson's disease	0.000572	0.00716	CbGeAlD
Imatinib—KIT—brainstem—Parkinson's disease	0.000569	0.00712	CbGeAlD
Imatinib—CA6—head—Parkinson's disease	0.000541	0.00677	CbGeAlD
Imatinib—ABL1—embryo—Parkinson's disease	0.00054	0.00676	CbGeAlD
Imatinib—PIP4K2C—head—Parkinson's disease	0.000536	0.00672	CbGeAlD
Imatinib—CA14—midbrain—Parkinson's disease	0.000536	0.00672	CbGeAlD
Imatinib—CA14—spinal cord—Parkinson's disease	0.000523	0.00655	CbGeAlD
Imatinib—CA3—head—Parkinson's disease	0.000512	0.00641	CbGeAlD
Imatinib—CSF1R—cardiovascular system—Parkinson's disease	0.000511	0.0064	CbGeAlD
Imatinib—PIP4K2C—nervous system—Parkinson's disease	0.000509	0.00637	CbGeAlD
Imatinib—ABL2—cerebellum—Parkinson's disease	0.000506	0.00633	CbGeAlD
Imatinib—CA1—forebrain—Parkinson's disease	0.000502	0.00628	CbGeAlD
Imatinib—CA7—cerebellum—Parkinson's disease	0.000498	0.00624	CbGeAlD
Imatinib—NQO2—medulla oblongata—Parkinson's disease	0.000497	0.00623	CbGeAlD
Imatinib—ABL1—brainstem—Parkinson's disease	0.000495	0.0062	CbGeAlD
Imatinib—PIP4K2C—central nervous system—Parkinson's disease	0.00049	0.00613	CbGeAlD
Imatinib—CA3—nervous system—Parkinson's disease	0.000486	0.00608	CbGeAlD
Imatinib—PIP4K2C—cerebellum—Parkinson's disease	0.000479	0.00599	CbGeAlD
Imatinib—CA3—central nervous system—Parkinson's disease	0.000468	0.00585	CbGeAlD
Imatinib—KIT—cardiovascular system—Parkinson's disease	0.000464	0.00581	CbGeAlD
Imatinib—SLC22A1—forebrain—Parkinson's disease	0.00046	0.00577	CbGeAlD
Imatinib—NQO2—midbrain—Parkinson's disease	0.000454	0.00569	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—Parkinson's disease	0.000453	0.00567	CbGeAlD
Imatinib—NQO2—spinal cord—Parkinson's disease	0.000443	0.00555	CbGeAlD
Imatinib—PDGFRA—spinal cord—Parkinson's disease	0.000442	0.00554	CbGeAlD
Imatinib—CA9—cerebellum—Parkinson's disease	0.000437	0.00548	CbGeAlD
Imatinib—CSF1R—medulla oblongata—Parkinson's disease	0.000437	0.00547	CbGeAlD
Imatinib—CA1—cardiovascular system—Parkinson's disease	0.000424	0.00531	CbGeAlD
Imatinib—CA14—cerebellum—Parkinson's disease	0.000415	0.0052	CbGeAlD
Imatinib—ABL2—brain—Parkinson's disease	0.000411	0.00514	CbGeAlD
Imatinib—CA7—brain—Parkinson's disease	0.000405	0.00507	CbGeAlD
Imatinib—ABL1—cardiovascular system—Parkinson's disease	0.000404	0.00506	CbGeAlD
Imatinib—CSF1R—midbrain—Parkinson's disease	0.000399	0.005	CbGeAlD
Imatinib—SLC47A1—medulla oblongata—Parkinson's disease	0.000399	0.00499	CbGeAlD
Imatinib—KIT—medulla oblongata—Parkinson's disease	0.000396	0.00496	CbGeAlD
Imatinib—NQO2—head—Parkinson's disease	0.000394	0.00493	CbGeAlD
Imatinib—Ponatinib—CYP2D6—Parkinson's disease	0.000394	0.0653	CrCbGaD
Imatinib—PDGFRA—head—Parkinson's disease	0.000393	0.00492	CbGeAlD
Imatinib—CSF1R—spinal cord—Parkinson's disease	0.000389	0.00487	CbGeAlD
Imatinib—PIP4K2C—brain—Parkinson's disease	0.000389	0.00487	CbGeAlD
Imatinib—PDGFRB—medulla oblongata—Parkinson's disease	0.000387	0.00485	CbGeAlD
Imatinib—NQO2—nervous system—Parkinson's disease	0.000374	0.00468	CbGeAlD
Imatinib—CYP2D6—hindbrain—Parkinson's disease	0.000373	0.00467	CbGeAlD
Imatinib—PDGFRA—nervous system—Parkinson's disease	0.000373	0.00467	CbGeAlD
Imatinib—CA3—brain—Parkinson's disease	0.000371	0.00465	CbGeAlD
Imatinib—CA2—embryo—Parkinson's disease	0.000368	0.0046	CbGeAlD
Imatinib—CA12—head—Parkinson's disease	0.000363	0.00454	CbGeAlD
Imatinib—KIT—midbrain—Parkinson's disease	0.000362	0.00454	CbGeAlD
Imatinib—NQO2—central nervous system—Parkinson's disease	0.00036	0.0045	CbGeAlD
Imatinib—PDGFRA—central nervous system—Parkinson's disease	0.000359	0.00449	CbGeAlD
Imatinib—SLC47A1—spinal cord—Parkinson's disease	0.000356	0.00445	CbGeAlD
Imatinib—PDGFRB—midbrain—Parkinson's disease	0.000354	0.00443	CbGeAlD
Imatinib—KIT—spinal cord—Parkinson's disease	0.000354	0.00443	CbGeAlD
Imatinib—NQO2—cerebellum—Parkinson's disease	0.000351	0.0044	CbGeAlD
Imatinib—PDGFRA—cerebellum—Parkinson's disease	0.000351	0.00439	CbGeAlD
Imatinib—CSF1R—head—Parkinson's disease	0.000346	0.00433	CbGeAlD
Imatinib—PDGFRB—spinal cord—Parkinson's disease	0.000345	0.00432	CbGeAlD
Imatinib—ABL1—medulla oblongata—Parkinson's disease	0.000345	0.00432	CbGeAlD
Imatinib—CA12—nervous system—Parkinson's disease	0.000344	0.00431	CbGeAlD
Imatinib—CA14—brain—Parkinson's disease	0.000337	0.00422	CbGeAlD
Imatinib—CA2—brainstem—Parkinson's disease	0.000337	0.00422	CbGeAlD
Imatinib—CA12—central nervous system—Parkinson's disease	0.000331	0.00415	CbGeAlD
Imatinib—CSF1R—nervous system—Parkinson's disease	0.000328	0.00411	CbGeAlD
Imatinib—CA2—forebrain—Parkinson's disease	0.000325	0.00407	CbGeAlD
Imatinib—ORM1—spinal cord—Parkinson's disease	0.000324	0.00406	CbGeAlD
Imatinib—CA1—spinal cord—Parkinson's disease	0.000323	0.00405	CbGeAlD
Imatinib—SLC47A1—head—Parkinson's disease	0.000316	0.00396	CbGeAlD
Imatinib—CSF1R—central nervous system—Parkinson's disease	0.000316	0.00395	CbGeAlD
Imatinib—ABL1—midbrain—Parkinson's disease	0.000315	0.00395	CbGeAlD
Imatinib—KIT—head—Parkinson's disease	0.000314	0.00393	CbGeAlD
Imatinib—CSF1R—cerebellum—Parkinson's disease	0.000309	0.00387	CbGeAlD
Imatinib—ABL1—spinal cord—Parkinson's disease	0.000308	0.00385	CbGeAlD
Imatinib—PDGFRB—head—Parkinson's disease	0.000307	0.00384	CbGeAlD
Imatinib—SLC47A1—nervous system—Parkinson's disease	0.0003	0.00375	CbGeAlD
Imatinib—KIT—nervous system—Parkinson's disease	0.000298	0.00373	CbGeAlD
Imatinib—PDGFRB—nervous system—Parkinson's disease	0.000291	0.00364	CbGeAlD
Imatinib—Nilotinib—CYP2D6—Parkinson's disease	0.000291	0.0482	CrCbGaD
Imatinib—SLC47A1—central nervous system—Parkinson's disease	0.000288	0.00361	CbGeAlD
Imatinib—CA1—head—Parkinson's disease	0.000287	0.0036	CbGeAlD
Imatinib—KIT—central nervous system—Parkinson's disease	0.000287	0.00359	CbGeAlD
Imatinib—NQO2—brain—Parkinson's disease	0.000286	0.00358	CbGeAlD
Imatinib—PDGFRA—brain—Parkinson's disease	0.000285	0.00357	CbGeAlD
Imatinib—SLC47A1—cerebellum—Parkinson's disease	0.000282	0.00353	CbGeAlD
Imatinib—Ponatinib—ABCB1—Parkinson's disease	0.000281	0.0467	CrCbGaD
Imatinib—KIT—cerebellum—Parkinson's disease	0.00028	0.00351	CbGeAlD
Imatinib—PDGFRB—central nervous system—Parkinson's disease	0.00028	0.00351	CbGeAlD
Imatinib—CA2—cardiovascular system—Parkinson's disease	0.000275	0.00344	CbGeAlD
Imatinib—PDGFRB—cerebellum—Parkinson's disease	0.000274	0.00343	CbGeAlD
Imatinib—ABL1—head—Parkinson's disease	0.000274	0.00342	CbGeAlD
Imatinib—ORM1—nervous system—Parkinson's disease	0.000273	0.00342	CbGeAlD
Imatinib—CA1—nervous system—Parkinson's disease	0.000272	0.00341	CbGeAlD
Imatinib—SLC22A1—head—Parkinson's disease	0.000264	0.0033	CbGeAlD
Imatinib—CA12—brain—Parkinson's disease	0.000263	0.00329	CbGeAlD
Imatinib—ORM1—central nervous system—Parkinson's disease	0.000263	0.00329	CbGeAlD
Imatinib—CA1—central nervous system—Parkinson's disease	0.000262	0.00328	CbGeAlD
Imatinib—ABL1—nervous system—Parkinson's disease	0.000259	0.00325	CbGeAlD
Imatinib—PTGS1—forebrain—Parkinson's disease	0.000251	0.00315	CbGeAlD
Imatinib—CSF1R—brain—Parkinson's disease	0.000251	0.00314	CbGeAlD
Imatinib—SLC22A1—nervous system—Parkinson's disease	0.00025	0.00313	CbGeAlD
Imatinib—ABL1—central nervous system—Parkinson's disease	0.00025	0.00313	CbGeAlD
Imatinib—ABL1—cerebellum—Parkinson's disease	0.000244	0.00306	CbGeAlD
Imatinib—SLC22A1—central nervous system—Parkinson's disease	0.000241	0.00301	CbGeAlD
Imatinib—CA2—medulla oblongata—Parkinson's disease	0.000235	0.00294	CbGeAlD
Imatinib—CYP2C9—cardiovascular system—Parkinson's disease	0.000233	0.00291	CbGeAlD
Imatinib—SLC47A1—brain—Parkinson's disease	0.000229	0.00287	CbGeAlD
Imatinib—KIT—brain—Parkinson's disease	0.000228	0.00285	CbGeAlD
Imatinib—PDGFRB—brain—Parkinson's disease	0.000222	0.00278	CbGeAlD
Imatinib—ABCG2—medulla oblongata—Parkinson's disease	0.000218	0.00273	CbGeAlD
Imatinib—CA2—midbrain—Parkinson's disease	0.000215	0.00269	CbGeAlD
Imatinib—CYP2D6—brainstem—Parkinson's disease	0.000214	0.00268	CbGeAlD
Imatinib—PTGS1—cardiovascular system—Parkinson's disease	0.000212	0.00266	CbGeAlD
Imatinib—CA2—spinal cord—Parkinson's disease	0.00021	0.00262	CbGeAlD
Imatinib—CA1—brain—Parkinson's disease	0.000208	0.00261	CbGeAlD
Imatinib—Nilotinib—ABCB1—Parkinson's disease	0.000207	0.0344	CrCbGaD
Imatinib—CYP2D6—forebrain—Parkinson's disease	0.000206	0.00259	CbGeAlD
Imatinib—ABCG2—midbrain—Parkinson's disease	0.000199	0.00249	CbGeAlD
Imatinib—ABL1—brain—Parkinson's disease	0.000198	0.00248	CbGeAlD
Imatinib—ABCG2—spinal cord—Parkinson's disease	0.000194	0.00243	CbGeAlD
Imatinib—SLC22A1—brain—Parkinson's disease	0.000191	0.00239	CbGeAlD
Imatinib—CA2—head—Parkinson's disease	0.000186	0.00233	CbGeAlD
Imatinib—ALB—brain—Parkinson's disease	0.000183	0.00229	CbGeAlD
Imatinib—CA2—nervous system—Parkinson's disease	0.000177	0.00221	CbGeAlD
Imatinib—CA2—central nervous system—Parkinson's disease	0.00017	0.00213	CbGeAlD
Imatinib—ABCB1—embryo—Parkinson's disease	0.000168	0.0021	CbGeAlD
Imatinib—CA2—cerebellum—Parkinson's disease	0.000166	0.00208	CbGeAlD
Imatinib—PTGS1—spinal cord—Parkinson's disease	0.000162	0.00203	CbGeAlD
Imatinib—ABCG2—cerebellum—Parkinson's disease	0.000154	0.00193	CbGeAlD
Imatinib—ABCB1—forebrain—Parkinson's disease	0.000149	0.00186	CbGeAlD
Imatinib—PTGS1—head—Parkinson's disease	0.000144	0.0018	CbGeAlD
Imatinib—PTGS1—nervous system—Parkinson's disease	0.000136	0.00171	CbGeAlD
Imatinib—CA2—brain—Parkinson's disease	0.000135	0.00169	CbGeAlD
Imatinib—PTGS1—central nervous system—Parkinson's disease	0.000131	0.00164	CbGeAlD
Imatinib—ABCB1—cardiovascular system—Parkinson's disease	0.000126	0.00157	CbGeAlD
Imatinib—ABCG2—brain—Parkinson's disease	0.000125	0.00157	CbGeAlD
Imatinib—CYP2D6—head—Parkinson's disease	0.000118	0.00148	CbGeAlD
Imatinib—CYP3A4—nervous system—Parkinson's disease	0.000114	0.00143	CbGeAlD
Imatinib—CYP2D6—nervous system—Parkinson's disease	0.000112	0.0014	CbGeAlD
Imatinib—CYP3A4—central nervous system—Parkinson's disease	0.00011	0.00137	CbGeAlD
Imatinib—CYP2D6—central nervous system—Parkinson's disease	0.000108	0.00135	CbGeAlD
Imatinib—ABCB1—medulla oblongata—Parkinson's disease	0.000107	0.00134	CbGeAlD
Imatinib—CYP2D6—cerebellum—Parkinson's disease	0.000105	0.00132	CbGeAlD
Imatinib—PTGS1—brain—Parkinson's disease	0.000104	0.00131	CbGeAlD
Imatinib—ABCB1—midbrain—Parkinson's disease	9.81e-05	0.00123	CbGeAlD
Imatinib—ABCB1—spinal cord—Parkinson's disease	9.57e-05	0.0012	CbGeAlD
Imatinib—CYP2D6—brain—Parkinson's disease	8.57e-05	0.00107	CbGeAlD
Imatinib—ABCB1—head—Parkinson's disease	8.5e-05	0.00106	CbGeAlD
Imatinib—ABCB1—nervous system—Parkinson's disease	8.06e-05	0.00101	CbGeAlD
Imatinib—ABCB1—central nervous system—Parkinson's disease	7.76e-05	0.000972	CbGeAlD
Imatinib—ABCB1—cerebellum—Parkinson's disease	7.59e-05	0.00095	CbGeAlD
Imatinib—ABCB1—brain—Parkinson's disease	6.16e-05	0.000772	CbGeAlD
Imatinib—SLC22A2—Metabolism—GSTP1—Parkinson's disease	6.68e-06	5.02e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MAOA—Parkinson's disease	6.67e-06	5.01e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOB—Parkinson's disease	6.67e-06	5.01e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MAOA—Parkinson's disease	6.66e-06	5.01e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—HMOX1—Parkinson's disease	6.65e-06	5e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—HMOX1—Parkinson's disease	6.6e-06	4.96e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—HMOX1—Parkinson's disease	6.59e-06	4.95e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PLA2G6—Parkinson's disease	6.57e-06	4.94e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2A—Parkinson's disease	6.55e-06	4.92e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—COMT—Parkinson's disease	6.51e-06	4.89e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOB—Parkinson's disease	6.51e-06	4.89e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GBA—Parkinson's disease	6.49e-06	4.88e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—FBP1—Parkinson's disease	6.49e-06	4.88e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DBH—Parkinson's disease	6.49e-06	4.88e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GSTP1—Parkinson's disease	6.48e-06	4.87e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MAOA—Parkinson's disease	6.47e-06	4.86e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—APOE—Parkinson's disease	6.43e-06	4.83e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	6.41e-06	4.82e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—HMOX1—Parkinson's disease	6.39e-06	4.8e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ABCB1—Parkinson's disease	6.39e-06	4.8e-05	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—Parkinson's disease	6.38e-06	4.79e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.34e-06	4.77e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL1B—Parkinson's disease	6.34e-06	4.77e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCB1—Parkinson's disease	6.33e-06	4.76e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCB1—Parkinson's disease	6.32e-06	4.75e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CTGF—Parkinson's disease	6.29e-06	4.73e-05	CbGpPWpGaD
Imatinib—LCK—Disease—APOE—Parkinson's disease	6.29e-06	4.72e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—COMT—Parkinson's disease	6.25e-06	4.7e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GSTP1—Parkinson's disease	6.22e-06	4.68e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MAOA—Parkinson's disease	6.21e-06	4.67e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GSTM1—Parkinson's disease	6.2e-06	4.66e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NGF—Parkinson's disease	6.2e-06	4.66e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	6.19e-06	4.65e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DDC—Parkinson's disease	6.17e-06	4.64e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GSTM1—Parkinson's disease	6.15e-06	4.62e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	6.14e-06	4.61e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—HMOX1—Parkinson's disease	6.14e-06	4.61e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCB1—Parkinson's disease	6.14e-06	4.61e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GSTM1—Parkinson's disease	6.14e-06	4.61e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOB—Parkinson's disease	6.13e-06	4.61e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—APOE—Parkinson's disease	6.09e-06	4.58e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOB—Parkinson's disease	6.08e-06	4.57e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—Parkinson's disease	6.04e-06	4.54e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL1B—Parkinson's disease	6e-06	4.51e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—Parkinson's disease	6e-06	4.51e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GSTM1—Parkinson's disease	5.96e-06	4.48e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GPX1—Parkinson's disease	5.94e-06	4.46e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—Parkinson's disease	5.9e-06	4.43e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCB1—Parkinson's disease	5.89e-06	4.43e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GPX1—Parkinson's disease	5.89e-06	4.42e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GPX1—Parkinson's disease	5.88e-06	4.41e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	5.86e-06	4.4e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTA4—Parkinson's disease	5.83e-06	4.38e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—MAPK8—Parkinson's disease	5.82e-06	4.37e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NQO1—Parkinson's disease	5.8e-06	4.35e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.79e-06	4.35e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.75e-06	4.32e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GSTM1—Parkinson's disease	5.72e-06	4.3e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TH—Parkinson's disease	5.71e-06	4.29e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GPX1—Parkinson's disease	5.7e-06	4.29e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF2—Parkinson's disease	5.67e-06	4.26e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CASP3—Parkinson's disease	5.58e-06	4.2e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP2D6—Parkinson's disease	5.52e-06	4.15e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—MAPK8—Parkinson's disease	5.51e-06	4.14e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—INS—Parkinson's disease	5.5e-06	4.13e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APOE—Parkinson's disease	5.49e-06	4.12e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYCS—Parkinson's disease	5.48e-06	4.12e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—Parkinson's disease	5.48e-06	4.12e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IGF1R—Parkinson's disease	5.48e-06	4.12e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GPX1—Parkinson's disease	5.48e-06	4.12e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—Parkinson's disease	5.44e-06	4.09e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—Parkinson's disease	5.43e-06	4.08e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—Parkinson's disease	5.42e-06	4.07e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CTGF—Parkinson's disease	5.42e-06	4.07e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EDN1—Parkinson's disease	5.41e-06	4.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—Parkinson's disease	5.41e-06	4.06e-05	CbGpPWpGaD
Imatinib—LCK—Disease—INS—Parkinson's disease	5.37e-06	4.04e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—Parkinson's disease	5.3e-06	3.98e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—Parkinson's disease	5.27e-06	3.96e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—Parkinson's disease	5.26e-06	3.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	5.25e-06	3.94e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—INS—Parkinson's disease	5.2e-06	3.91e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOB—Parkinson's disease	5.19e-06	3.9e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MAPK8—Parkinson's disease	5.13e-06	3.86e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APOE—Parkinson's disease	5.1e-06	3.83e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APOE—Parkinson's disease	5.06e-06	3.8e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—Parkinson's disease	5.05e-06	3.8e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APOE—Parkinson's disease	5.05e-06	3.79e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP2E1—Parkinson's disease	5.05e-06	3.79e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NQO1—Parkinson's disease	4.99e-06	3.75e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NGF—Parkinson's disease	4.98e-06	3.74e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MAPK8—Parkinson's disease	4.96e-06	3.73e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	4.95e-06	3.72e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.94e-06	3.71e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—TH—Parkinson's disease	4.92e-06	3.7e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APOE—Parkinson's disease	4.9e-06	3.68e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CTGF—Parkinson's disease	4.86e-06	3.65e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—COMT—Parkinson's disease	4.86e-06	3.65e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP2D6—Parkinson's disease	4.84e-06	3.63e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—MAPK8—Parkinson's disease	4.83e-06	3.63e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTP1—Parkinson's disease	4.83e-06	3.63e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOA—Parkinson's disease	4.82e-06	3.62e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—HMOX1—Parkinson's disease	4.77e-06	3.58e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DDC—Parkinson's disease	4.76e-06	3.58e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CTGF—Parkinson's disease	4.75e-06	3.57e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—Parkinson's disease	4.74e-06	3.56e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYCS—Parkinson's disease	4.72e-06	3.55e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APOE—Parkinson's disease	4.71e-06	3.54e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—INS—Parkinson's disease	4.69e-06	3.52e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCB1—Parkinson's disease	4.58e-06	3.44e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	4.53e-06	3.4e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	4.52e-06	3.39e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.5e-06	3.38e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NQO1—Parkinson's disease	4.48e-06	3.37e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.47e-06	3.36e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTM1—Parkinson's disease	4.44e-06	3.34e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CTGF—Parkinson's disease	4.43e-06	3.33e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP2E1—Parkinson's disease	4.42e-06	3.32e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TH—Parkinson's disease	4.42e-06	3.32e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOE—Parkinson's disease	4.4e-06	3.31e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NQO1—Parkinson's disease	4.37e-06	3.29e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—Parkinson's disease	4.36e-06	3.28e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—INS—Parkinson's disease	4.36e-06	3.27e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—Parkinson's disease	4.34e-06	3.26e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—INS—Parkinson's disease	4.32e-06	3.25e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—INS—Parkinson's disease	4.31e-06	3.24e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TH—Parkinson's disease	4.31e-06	3.24e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GPX1—Parkinson's disease	4.25e-06	3.2e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYCS—Parkinson's disease	4.24e-06	3.19e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—INS—Parkinson's disease	4.19e-06	3.15e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—COMT—Parkinson's disease	4.18e-06	3.14e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.17e-06	3.13e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTP1—Parkinson's disease	4.16e-06	3.13e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOA—Parkinson's disease	4.15e-06	3.12e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYCS—Parkinson's disease	4.14e-06	3.11e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	4.13e-06	3.1e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.12e-06	3.1e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—HMOX1—Parkinson's disease	4.11e-06	3.08e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CASP3—Parkinson's disease	4.09e-06	3.07e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NQO1—Parkinson's disease	4.09e-06	3.07e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TH—Parkinson's disease	4.06e-06	3.05e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.05e-06	3.04e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TH—Parkinson's disease	4.03e-06	3.03e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—INS—Parkinson's disease	4.02e-06	3.02e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.01e-06	3.01e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—MAPK8—Parkinson's disease	3.98e-06	2.99e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCB1—Parkinson's disease	3.94e-06	2.96e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—Parkinson's disease	3.93e-06	2.95e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.9e-06	2.93e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CASP3—Parkinson's disease	3.87e-06	2.91e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYCS—Parkinson's disease	3.87e-06	2.9e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.86e-06	2.9e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTM1—Parkinson's disease	3.83e-06	2.87e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.79e-06	2.85e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—INS—Parkinson's disease	3.76e-06	2.83e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MAPK8—Parkinson's disease	3.76e-06	2.83e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—COMT—Parkinson's disease	3.76e-06	2.82e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.74e-06	2.81e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.73e-06	2.8e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—Parkinson's disease	3.71e-06	2.79e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.69e-06	2.77e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—COMT—Parkinson's disease	3.67e-06	2.75e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GPX1—Parkinson's disease	3.66e-06	2.75e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOE—Parkinson's disease	3.65e-06	2.75e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTP1—Parkinson's disease	3.65e-06	2.74e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOA—Parkinson's disease	3.64e-06	2.73e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.6e-06	2.7e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MAPK8—Parkinson's disease	3.56e-06	2.67e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB1—Parkinson's disease	3.54e-06	2.66e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	3.53e-06	2.65e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—Parkinson's disease	3.52e-06	2.64e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NQO1—Parkinson's disease	3.49e-06	2.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CASP3—Parkinson's disease	3.49e-06	2.62e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—COMT—Parkinson's disease	3.45e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TH—Parkinson's disease	3.44e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.44e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTM1—Parkinson's disease	3.43e-06	2.58e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—Parkinson's disease	3.43e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.43e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—COMT—Parkinson's disease	3.42e-06	2.57e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTP1—Parkinson's disease	3.41e-06	2.56e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOA—Parkinson's disease	3.4e-06	2.55e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.39e-06	2.55e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—Parkinson's disease	3.38e-06	2.54e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HMOX1—Parkinson's disease	3.36e-06	2.53e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTM1—Parkinson's disease	3.35e-06	2.52e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYCS—Parkinson's disease	3.3e-06	2.48e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GPX1—Parkinson's disease	3.29e-06	2.47e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—Parkinson's disease	3.28e-06	2.46e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.25e-06	2.44e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—Parkinson's disease	3.25e-06	2.44e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB1—Parkinson's disease	3.23e-06	2.42e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GPX1—Parkinson's disease	3.21e-06	2.41e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MAPK8—Parkinson's disease	3.21e-06	2.41e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—Parkinson's disease	3.17e-06	2.38e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.16e-06	2.37e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—Parkinson's disease	3.15e-06	2.37e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTM1—Parkinson's disease	3.13e-06	2.35e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—INS—Parkinson's disease	3.12e-06	2.35e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—Parkinson's disease	3.09e-06	2.32e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.04e-06	2.28e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.02e-06	2.27e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GPX1—Parkinson's disease	3e-06	2.25e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.98e-06	2.24e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.96e-06	2.23e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—COMT—Parkinson's disease	2.93e-06	2.2e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—Parkinson's disease	2.92e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.92e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.91e-06	2.19e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.91e-06	2.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.87e-06	2.16e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—Parkinson's disease	2.83e-06	2.12e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CASP3—Parkinson's disease	2.8e-06	2.1e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.79e-06	2.1e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—Parkinson's disease	2.77e-06	2.08e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—Parkinson's disease	2.76e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.76e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.73e-06	2.05e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.69e-06	2.02e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—INS—Parkinson's disease	2.69e-06	2.02e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.68e-06	2.01e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TH—Parkinson's disease	2.66e-06	2e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—Parkinson's disease	2.6e-06	1.95e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—Parkinson's disease	2.58e-06	1.94e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MAPK8—Parkinson's disease	2.57e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.56e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.55e-06	1.92e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—Parkinson's disease	2.54e-06	1.91e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—INS—Parkinson's disease	2.41e-06	1.81e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—Parkinson's disease	2.4e-06	1.8e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.36e-06	1.78e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—INS—Parkinson's disease	2.36e-06	1.77e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—Parkinson's disease	2.35e-06	1.76e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—Parkinson's disease	2.27e-06	1.71e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—COMT—Parkinson's disease	2.26e-06	1.7e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.25e-06	1.69e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.24e-06	1.68e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—INS—Parkinson's disease	2.22e-06	1.67e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.22e-06	1.67e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—Parkinson's disease	2.2e-06	1.65e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—INS—Parkinson's disease	2.2e-06	1.65e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.13e-06	1.6e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.07e-06	1.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—Parkinson's disease	2.05e-06	1.54e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.98e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—INS—Parkinson's disease	1.88e-06	1.41e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.83e-06	1.37e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—Parkinson's disease	1.7e-06	1.28e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—Parkinson's disease	1.64e-06	1.23e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—INS—Parkinson's disease	1.45e-06	1.09e-05	CbGpPWpGaD
